Trader Edge / parameter - TLDR Eli Lilly (LLY) announced a deal to buy Orna Therapeutics for up to $2.4 billion in cash to expand its cell therapy capabilities. Orna’s lead asset ORN-252 uses circular RNA technology to create CAR-T therapies inside patients’ bodies for autoimmune …
Back to Top / Monday, February 9, 2026, 11:22 am / permalink 18943 / 3 stories in 25 days
Novartis Acquires Avidity Biosciences for $12 Billion Expansion / 4 months
Nobel Prize honors breakthroughs in immune tolerance research / 5 months
UK biotech Nuclera secures Series C funding for advanced protein research / 7 wks
IVFmicro secures £3.5M to boost IVF treatment technology / 2 months
Sofinnova Partners Closes €650M Biopharma & MedTech Fund / 3 months
Bedfordshire biotech Tozaro raises funding to scale gene-therapy platform / 18 days
QT Sense raises €4M for real‐time cellular stress monitoring / 4 wks
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.